SG11201701502VA - A process for the production of adenovirus - Google Patents

A process for the production of adenovirus

Info

Publication number
SG11201701502VA
SG11201701502VA SG11201701502VA SG11201701502VA SG11201701502VA SG 11201701502V A SG11201701502V A SG 11201701502VA SG 11201701502V A SG11201701502V A SG 11201701502VA SG 11201701502V A SG11201701502V A SG 11201701502VA SG 11201701502V A SG11201701502V A SG 11201701502VA
Authority
SG
Singapore
Prior art keywords
adenovirus
production
Prior art date
Application number
SG11201701502VA
Inventor
Brian Robert Champion
Jeetendra Bhatia
Ashvin Patel
Original Assignee
Psioxus Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB201415154A external-priority patent/GB201415154D0/en
Priority claimed from GB201415581A external-priority patent/GB201415581D0/en
Application filed by Psioxus Therapeutics Ltd filed Critical Psioxus Therapeutics Ltd
Publication of SG11201701502VA publication Critical patent/SG11201701502VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
SG11201701502VA 2014-08-27 2015-08-27 A process for the production of adenovirus SG11201701502VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201415154A GB201415154D0 (en) 2014-08-27 2014-08-27 A process for the production of adenovirus
GB201415581A GB201415581D0 (en) 2014-09-03 2014-09-03 A Process
PCT/EP2015/069706 WO2016030489A2 (en) 2014-08-27 2015-08-27 A process for the production of adenovirus

Publications (1)

Publication Number Publication Date
SG11201701502VA true SG11201701502VA (en) 2017-03-30

Family

ID=54062727

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201701502VA SG11201701502VA (en) 2014-08-27 2015-08-27 A process for the production of adenovirus

Country Status (6)

Country Link
US (1) US20170313990A1 (en)
EP (1) EP3186366A2 (en)
JP (1) JP2017529070A (en)
KR (1) KR20170044194A (en)
SG (1) SG11201701502VA (en)
WO (1) WO2016030489A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3777870A1 (en) 2013-06-14 2021-02-17 Psioxus Therapeutics Limited A dosing regime and formulations for type b adenoviruses
CA2927968C (en) 2013-10-25 2023-02-21 Psioxus Therapeutics Limited Oncolytic adenoviruses armed with heterologous genes
AU2016372576A1 (en) 2015-12-17 2018-06-21 Psioxus Therapeutics Limited Virus encoding an anti-TCR-complex antibody or fragment
US11542332B2 (en) 2016-03-26 2023-01-03 Bioatla, Inc. Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof
SG11201901716TA (en) * 2016-08-29 2019-03-28 Psioxus Therapeutics Ltd Adenovirus armed with bispecific t cell engager (bite)
GB201713765D0 (en) 2017-08-28 2017-10-11 Psioxus Therapeutics Ltd Modified adenovirus
HUE063274T2 (en) * 2017-06-01 2024-01-28 Akamis Bio Ltd Oncolytic virus and method
EP4259172A1 (en) * 2020-12-10 2023-10-18 AstraZeneca UK Limited Methods of producing adenovirus
WO2022170219A1 (en) 2021-02-05 2022-08-11 Iovance Biotherapeutics, Inc. Adjuvant therapy for cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3447097A (en) * 1996-07-01 1998-01-21 Rhone-Poulenc Rorer S.A. Method for producing recombinant adenovirus
GB9915413D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Propagation method
CA2836987C (en) * 2004-05-26 2016-07-05 Psioxus Therapeutics Limited Chimeric adenoviruses for use in cancer treatment
CA2673520A1 (en) 2006-12-22 2008-07-03 Bayer Schering Pharma Aktiengesellschaft Generation of oncolytic adenoviruses and uses thereof
US8470585B2 (en) 2009-10-15 2013-06-25 Crucell Holland B.V. Process for adenovirus purification from high cell density cultures
WO2014131898A1 (en) * 2013-02-28 2014-09-04 Psioxus Therapuetics Limited A process for the production of adenovirus
CA2927968C (en) 2013-10-25 2023-02-21 Psioxus Therapeutics Limited Oncolytic adenoviruses armed with heterologous genes

Also Published As

Publication number Publication date
WO2016030489A2 (en) 2016-03-03
KR20170044194A (en) 2017-04-24
EP3186366A2 (en) 2017-07-05
US20170313990A1 (en) 2017-11-02
WO2016030489A3 (en) 2016-04-21
JP2017529070A (en) 2017-10-05

Similar Documents

Publication Publication Date Title
HRP20201847T1 (en) Process for the preparation of a diarylthiohydantoin compound
PL3201253T3 (en) Process for the production of polyesters
SG11201701502VA (en) A process for the production of adenovirus
ZA201701011B (en) Steel-strip production apparatus
PL3129335T3 (en) Process for making tiles
PL3129356T3 (en) A process for producing enzalutamide
GB2522421B (en) LNG production process
HUE055687T2 (en) Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
GB201506074D0 (en) Object production
GB201413778D0 (en) Methanol production process
SG11201704523WA (en) A process for the manufacture of idalopirdine
GB201415579D0 (en) A process
PT3182981T (en) Process for the production of isomaltooligosaccharides
GB2532451B (en) Object production
GB201419454D0 (en) New process
IL252471A0 (en) A process for the manufacture of idalopirdine
GB201406364D0 (en) Lactate production process
GB201415154D0 (en) A process for the production of adenovirus
GB201418664D0 (en) Methods for the production of 2-D materials
GB201407180D0 (en) Object production
GB201407184D0 (en) Object production
GB201415581D0 (en) A Process
AU2014900341A0 (en) Production process